Exercise intolerance, as evidenced by a worsening of pain, fatigue, and stiffness after novel exertion, is a key feature of fibromyalgia (FM). In this pilot study, we investigate whether; insufficient muscle repair processes and impaired anti-inflammatory mechanisms result in an exaggerated pro-inflammatory cytokine response to exhaustive exercise, and consequently a worsening of muscle pain, stiffness and fatigue in the days postexercise. We measured changes in muscle pain and tenderness, fatigue, stiffness, and serum levels of neuroendocrine and inflammatory cytokine markers in 20 women with FM and 16 healthy controls (HCs) before and after exhaustive treadmill exercise. Compared to HCs, FM participants failed to mount the expected anti-inflammatory response to exercise and experienced a worsening of symptoms post-exercise. However, changes in postexertional symptoms were not mediated by post-exertional changes in pro-inflammatory cytokine levels. Implications of these findings are discussed.
Introduction
Fibromyalgia (FM) is a chronic and often debilitating disorder characterized by widespread pain; other symptoms commonly include tenderness, stiffness, fatigue, sleep, mood disturbances and reports of worsening symptoms following novel exertion. FM affects an estimated 11 million persons in the United States, 80-90% of whom are women (Queiroz, 2013) . FM patients are typically sedentary and overweight or obese (Yunus et al., 2002) with physical inactivity contributing to an increased risk for metabolic related co-morbidities in this population (Loevinger et al., 2007) . Regular exercise is a key component of most comprehensive FM-management programs (Busch et al., 2013) . Of the N120 exercise interventions in FM, most have failed to meet the current exercise recommendation for health by The American College of Sports Medicine (ACSM) and the American Heart Association (AHA) guidelines. These organizations recommend moderate to vigorous intensity exercise to prevent adverse health outcomes related to sedentary lifestyles (Nelson et al., 2007; Garber et al., 2011; Busch et al., 2013) . Prior exercise studies modified for FM suggest that individuals who can tolerate the intervention can improve aerobic capacity, muscle strength, balance and flexibility and attain some symptom relief, particularly decreased pain, tenderness, fatigue, and stiffness (Busch et al., 2013 ). Yet FM patients often reported several days of increased pain and tenderness following moderate to high-intensity exercise, which may explain why many of these prior exercise interventions suffered from high attrition rates and inconsistent effect sizes (Jones et al., 2006) . FM represents an important clinical population that would benefit from establishing specific exercise guidelines that would maximize benefits while minimizing post-exertional symptom exacerbation. Understanding the molecular mechanisms underlying FM symptom exacerbation following moderate to high-intensity exercise may help to guide the development of exercise guidelines in FM. The overall hypothesis guiding the present study is that increased post-exertional symptom exacerbation in FM is related to an abnormal neuroendocrine and immune system response to moderate to high-intensity exercise. Consistent with this hypothesis are reports of a blunted GH response to high-intensity exercise and lower resting levels of its primary downstream effecter, insulin-like growth factor 1 (IGF-1), in people with FM (Paiva et al., 2002; Ross et al., 2010; Bote et al., 2012) . GH is just one of several neuroendocrine and inflammatory factors including ACTH, cortisol, IL-6, IL-10, and IL-1RA that are up-regulated during exercise (Walsh et al., 2011) . The exercise-induced inflammatory cytokine response was originally attributed to muscle microtrauma (Bruunsgaard et al., 1997) , which can occur during high-intensity exercise or unnacustomed exercise in a deconditioned individual. Muscle microtrauma triggers the localized production of the proinflammatory cytokines IL-1β and TNF-α which promote the infiltration of immune cells into the damaged area. These infiltrating immune cells secrete IL-1β, TNF-α and other inflammatory molecules including IL-6, IL-8, IL-1RA and IL-10 (Nieman et al., 2006a, 2006b) . The ability of IL-1β and TNF-α to stimulate muscle nociceptors likely explains the characteristic pain and tenderness following muscle damaging exercise (Borghi et al., 2014a (Borghi et al., , 2014b . In addition IL-1β and TNF-α play a central role in the development of sickness behavior, the predominant symptom of which is fatigue (Dantzer, 2009 ). However, it has since been shown that exercise-induced increases in circulating IL-6, IL-10, and IL-1RA can occur in the absence of muscle microtrauma, and in this context their production is not preceded by IL-1β or TNF-α (Welc and Clanton, 2013) . Further studies revealed that the predominant source of IL-6 released during non-muscle damaging exercise is exercising muscle cells which led to the classification of IL-6 as a "myokine" (Pedersen and Febbraio, 2012) . Exercise-induced increases in circulating ACTH, GH, cortisol, IL-10, and IL-1RA can be attributed to musclederived IL-6 (Traustadottir et al., 2004; Walsh et al., 2011; Bote et al., 2012) . By stimulating the production of anti-inflammatory molecules such as cortisol, IL-1RA, and IL-10, muscle-derived IL-6 has a net antiinflammatory effect and elevated IL-6 either from infusion or exercise can decrease TNF-α levels in both rodents and humans (Starkie et al., 2003; Petersen and Pedersen, 2005; Ploeger et al., 2009) . GH regulates the synthesis of IGF-1 which plays an important role in controlling the pro-inflammatory cytokine response to muscle microtrauma and coordinating the repair processes thereafter (Matheny et al., 2010) . Taken together, we concluded that insufficient muscle repair processes (GH/IGF-1 axis defect) and impaired anti-inflammatory mechanisms (blunted cortisol, IL-10 and IL-1RA) in FM would result in an exaggerated pro-inflammatory cytokine response (elevated IL-1β, TNF-α, IL-6, and IL-8) to unaccustomed exercise and consequently a worsening of muscle pain, stiffness and fatigue in the days post-exercise. The purpose of the present study was to generate preliminary evidence to support this hypothesis.
Methods and procedures

Inclusion and exclusion criteria
The target FM population was women less than 60 years of age, diagnosed with FM by 1990 ACR criteria for at least two years, who had experienced FM symptoms ≥6 years, and were willing to undergo the testing protocol. The upper age cut-off was chosen to reduce the risk of adverse cardiac event during treadmill stress testing. Healthy controls (HCs) were women pair matched to FM patients (see below). Exclusion criteria for both groups were; 1) regular participation in aerobic or strength programs for more than 30 min three times a week, 2) pregnant or nursing, 3) major depressive disorder, 4) daily use of opioids, 5) current or past malignancy, 6) major organ disease or autoimmune/inflammatory disease, 7) elective surgery 30 days prior or during the 12 day study, and 8) involvement in disability litigation hearings. Participants were requested not to change medications or non-pharmacologics (e.g., exercise, physical therapy) during the course of the 12-day study.
Procedure for participant recruitment
A database of confirmed FM patients managed by the Fibromyalgia Information Foundation was used for subject recruitment. Field codes identified zip code, age and sex for inclusion/exclusion criteria and demographics. E-Blasts were sent to 344 potential subjects. Of those, 86 candidates completed an online interest form and were called for a telephone screening by research staff. At that point, the potential subjects were asked to confirm further inclusion/exclusion criteria and then scheduled for a study appointment. The HC participants were recruited using an interested person database repository of previous research participants who gave consent to be re-contacted for other research opportunities, and in addition, participants were recruited by posting a local craigslist ad in the Portland Metro area. Eligibility of interested persons was assessed by phone. Interested and eligible HC participants were then evaluated based on age, estimated BMI to determine whether they may be a potential 'match' for an FM patient enrolled in the study. In total, 87 interested women responded to recruitment material as HCs and of those, 17 were eligible and confirmed matches. Once a match was confirmed, the HC participant was scheduled for the study testing procedures. One HC participant was unable to complete the treadmill testing due to an acute illness during the 12-day protocol, so 16 women completed the entire protocol as HC matches. FM and HCs were females matched ton age (± 5 years), percentage of body fat (±15%), and menopausal status. There were 4 FM patients that were included in the present analysis for which no matched control could be identified.
Procedure overview
Eligible participants underwent four study visits during 12-days of data collection. At Visit 1 (Day 1), written informed consent was obtained and participants underwent a manual tender-point assessment and completed the Revised Beck Depression Inventory (BDI-R) questionnaire to confirm eligibility. Each participant then underwent pressure pain threshold (PPT) testing and body composition testing by DEXA to measure the percentage of body fat. Visit 2 occurred between 8 and 11:00 am 7-days after Visit 1 with fasting treadmill exercise to VO 2 peak using the modified Balke protocol (ACSM Guidelines). The modified Balke protocol was chosen for this study because the incremental increase in exercise intensity is gradual but still allows for the accurate assessment of V0 2 peak in FM patients. In addition, this protocol has been used previously to examine the GH response to exhaustive exercise (Paiva et al., 2002; Jones et al., 2007) . Upon arrival at the CTU participants had an indwelling intravenous catheter placed in their forearms by a study nurse 1 h prior to the treadmill test. During this hour, participants completed study surveys. Blood was collected through the catheter three times during the treadmill test; immediately before exercise, at peak exercise (VO 2 peak), and then 60-minutes after peak exercise. All participants returned 2-and 4-days after the treadmill test for repeat PPT assessments and peripheral blood draws, and completion of the FIQR/SIQR (Day 4 post-exercise only). The study protocol was approved by the University's Institutional Review Board.
Demographic data
Demographic data was obtained using an investigator-designed questionnaire (disability, menopausal status and hormone replacement therapy in women, medications, and duration of FM).
Revised Fibromyalgia Impact Questionnaire (FIQR) and the Revised Symptom Impact Questionnaire (SIQR)
Participants completed the FIQR or SIQR at the beginning and end of the study period. The FIQR is a self-report 21-item instrument that assesses symptoms during the past week using a 0 to 10 scale (Bennett et al., 2009) . The FIQR has three domains: physical function, overall effect of FM, and FM symptoms (pain, fatigue, un-refreshing sleep, stiffness, anxiety, depression, tenderness to touch, memory, balance and environmental sensitivity). The SIQR is the same as the FIQR except the word fibromyalgia is replaced with "symptom." The SIQR is used to assess symptomatology in non-fibromyalgia patients (Friend and Bennett, 2011) . Only the fatigue and stiffness scores were used in the present study.
Revised Beck Depression Inventory (BDI-R)
The BDI-R was used to screen for major depression since depression is hypothesized to alter the neuroendocrine and inflammatory axes (Pariante and Lightman, 2008; Dantzer, 2012) . The BDI-R is the standard, 21-item BDI scale for assessment of depressive symptoms and behaviors which has been adapted for use with FM patients. This adaptation has better accuracy, sensitivity, and specificity in an FM population than the original instrument (Burckhardt et al., 1994) .
The Manual Tenderpoint Survey (MTPS)
Overall tender point tenderness was performed at the beginning of the study period. FM patients rated their pain level during digital palpation of each of 18 tender points on a 0 to 10 scale with 0 meaning no pain and 10 meaning worst pain. A pain rating of 2 was required to count a tender point as positive. The Fibromyalgia Tender Point Score (FTPS) was determined by averaging the 18 tender point scores.
Anthropometrics
A stadiometer was used to measure height to the nearest 0.1 cm. Weight was measured to the nearest 0.1 kg (with shoes, socks and headgear removed) using a single pair of electronic scales. BMI (weight in kg/height in m 2 ) was calculated. Whole body fat mass and percentage of whole body fat were obtained by whole body dual energy X-ray absorptiometry (DXA) (Hologic QDR Discovery Densitometer, Hologic, Inc., Bedford, MA; software version 12.0). DXA scans were performed by a licensed technician who was responsible for proper positioning, scan protocol, and scan analysis. Participants wore minimal clothing and were scanned in the supine position. The percentage of whole body fat (%Whole Body Fat = 100 − (%Whole Body Lean Mass + %Whole Body Bone Mineral Content)) was calculated/was obtained and used to pair match FM and HC within ± 15% of Whole Body Fat Mass. Hip and waist circumference were measured and hip to waist ratio calculated.
Pressure algometry
The pain pressure threshold (PPT) was assessed over the lower, mid, and upper anterior thigh and the nail bed of the thumb before the start of the study and then 2-and 4-days after the exercise test. PPT was measured using a Fisher's hand held dolorimeter. Pressure at a rate of approximately 1 kg/cm 2 per second was applied until the subject indicated that the sensation changed from pressure to pain. The PPT for each test site and both legs were summed.
2.3.7. Fasting treadmill exercise to VO 2 peak Participants completed the modified Balke treadmill test after fasting for 12-hours (water allowed) and abstaining from all pain medications on the morning of the treadmill testing. All treadmill tests were performed between 8 am and 11 am. Participants were fitted with 12 ECG electrodes and a Hans-Rudolph respiratory exchange mask. They were asked to walk on a treadmill (SMC2000) using the modified Balke protocol for VO 2 peak testing (Burckhardt et al., 1989) . Briefly, treadmill speed was set at 2.0 mph; 0% grade for 3 min, then elevation increase of 2.5% every 3 min until a 17.5% grade was achieved and then speed increased to 3.0 mph; 12.5% grade for 3 min, then elevation increase of 2.5% every 3 min until 20% grade. Respiratory gas exchange was measured using a metabolic cart (Sensor Medics VMAX 29). Continuous monitoring of ECG, pulse rate, and blood pressure was performed using a Sensor Medics Cardiosoft ECTG system. The maximal treadmill exercise test was defined when either of 2 goals were met: 1) respiratory exchange ratio (RER) N1.1 for 30 consecutive seconds, or 2) exhaustion scale (Borg) value of 10 (maximum perceived effort). The neuroendocrine and inflammatory responses to exercise are dependent upon how vigorous the exercise is and its duration. Thus, work performed by each participant was calculated using the following equation: peak workload = (distance/time) ×treadmill grade × weight. Relative VO 2 peak (mL/Kg/min) was used as a measure of physical fitness and time spent on the treadmill was used as a measure of physical endurance.
Blood collection and measurement of neuroendocrine and inflammatory serum markers
During the treadmill test, 10 mL of peripheral blood was collected from a peripheral intravenous lock at 1) pre-exercise, 2) peak-exercise (VO 2 peak), and 3) 60-minute post-peak exercise. Following the treadmill test, the participant refrained from eating until after the 3rd blood draw (1-hour post-exercise) because hyperglycemia can dampen the GH response to exercise. Blood was allowed clotting for 4-hours at room temperature before centrifugation at 2000 ×g for 20 min at room temperature. Serum was removed, aliquoted then immediately stored at −87°C before analysis. Samples were frozen and thawed no more than twice prior to analysis. Serum GH, ACTH, IL-1β, IL-6, IL-8, IL-10, IL-1RA, and TNF-α were measured using bead-based immunofluorescence assays commercially available from Millipore Inc. Assays were run in triplicate according to the manufacturers' protocol. A fiveparameter regression formula was used to calculate the sample concentrations from the standard curves. Data were collected and analyzed using the Luminex-100 system Version IS (Luminex, Austin, TX). Serum cortisol was measured in duplicate by a chemiluminescent immunoassay using the automated immulite system (Siemens Healthcare Diagnostics, Tarrytown, NY 10591). This assay has an analytical sensitivity of 0.2 μg/dL and the average percent difference between duplicates was 5.5%.
Analysis
Serum analyte data were not normally distributed, and so data were subjected to logarithmic transformation (Ln) before all statistical analyses. One way ANOVA was used to test for differences in continuous variables at baseline, and the χ 2 test was used for categorical variables. A two (FM vs. HC) × 3 (pre-, peak-, and post-exercise) repeated measure ANOVA was used to analyze differences in exercise-induced changes in serum neuroendocrine and inflammatory analytes and PPT between FM and HCs. Both linear and quadratic contrasts were tested on the time effect. Mauchley's test was used to test for sphericity and if violated tests with adjusted df were used (Greenhouse-Geisser). Change in fatigue and stiffness was calculated from pre-and post-exercise FIQR and SIQR scores. All data are presented as mean ± standard error of the mean (SEM). Primary analyses were conducted with the R statistical software package (R Core Team, 2014) . Exploratory mediation analyses were performed using Mplus statistical software, which allows the direct estimation of mediating (indirect) effects. Mediation models were only tested for serum neuroendocrine and inflammatory analytes and symptom outcomes that were significantly different across patient group (FM versus HCs).
Results
Demographics
Demographic data is shown in Table 1 . The total sample was Caucasian (91.7%), non-Hispanic (94.4%), in a committed relationship (72.2%), employed (50% working at least part-time outside of the home) and receiving income (77.8% earning less than $99,999/year). There were no differences between the two groups in ethnicity, race, marital status, employment, income level, menopausal status, or estrogen status. There was a near significant group difference in education; 75% of HCs were college graduates compared to only 40% of women in the FM group.
Baseline characteristics
Baseline characteristics of the FM and control participants are shown in Table 2 . There were no significant group differences in age, percentage of body fat, or hip to waist ratio. None of the participants met the criteria for major clinical depression based on scores from the BDI-R. There was no significant difference between FM and HCs in total BDI-R score. Consistent with the ACR criteria for the classification of FM, FM patients had higher tender point ratings than HCs. None of the HCs met the 1990 ACR diagnostic criteria for FM. FM participants had higher levels of muscle tenderness in the quadriceps muscles on PPT testing compared to HCs. As expected levels of bodily pain, fatigue and stiffness levels, based on the FIQR/SIQR results, were significantly higher in FM subjects than HCs.
Neuroendocrine and inflammatory cytokine response to exercise
All participants completed the Modified Balke treadmill protocol to volitional exhaustion (Table 3) . Seventy five percent of controls and 65% of FM participants ending the test by reaching a 10 on the 1-10 BORG Rating of Perceived Exertion scale, and 25% of controls and 35% of FM patients reached an RER N 1.1 to define their VO 2 peak. There were no differences in the reason for ending exercise, physical fitness, physical endurance workload RER resting heart rate (HR) or maximum HR. Fig. 1 shows plots of serum ACTH, GH, and cortisol levels collected pre-, peak-, and post-exercise. We observed a significant quadratic group by time interaction accounting for 13% of the variance of ACTH levels across time (F(1,34) = 5.05, p = .03, η p = .13). ACTH levels increased in HCs during exercise, peaked at the end of exercise and returned to baseline thereafter. This ACTH response was absent in FM participants. Although a similar quadratic pattern was observed for serum GH levels, there was not a significant difference between the FM or HC groups (F(1,32) = .04, p = .84). A near significant linear time by group interaction accounted for 10% of the variance in cortisol levels across time (F(1,34) = 3.95, p = .06, η p = .10). Fig. 2 shows plots of serum IL-6, IL-10, TNF-α, and IL-8 levels during the exercise test and 2-and 4-days thereafter. Levels of IL-1β and IL-1RA were below the threshold of detection in greater than 60% of samples screened and therefore these data are not shown. There was significant linear group by time interaction accounting for 12% of the variance in IL-6 levels across time (F(1,34) = 4.57, p = .04, η p = .12). There was also a significant quadratic group by time interaction accounting for 21% of the variance in IL-10 levels across time (F(1,34) = 9.08, p = .005, η p = .21). While IL-6 increased in both FM and HCs during the exercise test, post-exercise levels fell more rapidly in the HCs than in the FM group. The difference between HCs and FMs in the pattern of change SEM is standard error of the mean. BDI-R is the Beck Depression Inventory-Revised. FIQR is the Revised Fibromyalgia Impact Questionnaire. SIQR is the Revised Symptom Impact Questionnaire. VAS = Visual Analogue Scale. Values are the mean ± SEM.
Neuroendocrine response during exercise
Inflammatory cytokine response during and after exercise
in IL-10 was more striking than for IL-6. HCs mounted an IL-10 response during exercise this response was blunted in the FM group. For TNF-α, a significant linear group by time interaction accounted for 30% of the variance in the levels across time (F(1,34) = 14.34, p = .001, η p = .30).
Whereas exercise decreased serum TNF-α in HCs, it had a very small stimulatory effect on TNF-α level in the FM group. There was also a significant linear group by time interaction accounting for 12% of the variance in IL-8 levels across time (F(1,34) = 4.51, p = .04, η p = .12). A sharper decline in serum IL-8 levels in the 60 min post-exercise was observed in the HCs compared to the FM group. We then examined changes in IL-6, IL-10, TNF-α, and IL-8 between the HC and FM groups from pre-exercise to -and 4-days after exercise. There were no significant group by time interactions for IL-6 (F(2,68) = .86, p = .43), or IL-10 (F(1,68) = 1.53, p = .22) or TNF-α levels across time (F(2,68) = 1.28, p = .29). We did observe a significant quadratic group by time interaction accounting for 21% of the variance in IL-8 ) and HCs (closed square) collected at pre-exercise (pre), at VO 2 peak (peak), 1-hour after VO 2 peak (Post), 2-days after exercise (Day 2), and 4-days after exercise (Day 4). Each data point represents the mean ± SEM. Serum analyte data were not normally distributed and so data was subjected to logarithmic transformation (Ln) before all statistical analyses. A 2 (FM vs. HC) × 3 (pre-, peak-, and post-) and repeated measure ANOVA was used to analyze differences in exercise-induced changes during exercise, and a 2 (FM vs. HC) × 3 (pre-, Day 2, and Day 4) repeated measure ANOVA was used to analyze differences in post-exertional changes in each inflammatory analyte.
scores across time (F(1,34) = 8.84, p = .005, η p = .21). In HCs, IL-8 levels at 2-and 4-days post-exercise were similar to pre-exercise levels, whereas they decreased in FM participants.
Post-exertional pain, tenderness, fatigue and stiffness
Change in local pain and tenderness in the upper thigh muscles was assessed using the PPT test at baseline, then 2 days and 4 days postexercise. There was a significant linear group × time interaction that accounted for 27% of the variance in PPT scores across time. FM patients experienced lower thresholds for pain and greater local tenderness whereas controls experienced higher thresholds for pain and less local tenderness following the exercise test (F(1,33) = 6.24, p = .001, η p = .27; Fig. 3A) . In contrast, exercise had no group effect on change in pain and tenderness of the thumb, the control site (p = .463). Change in fatigue and stiffness was calculated from pre-and post-exercise FIQR/ SIQR scores. FM participants reported significantly greater changes in fatigue (1.3 ± 0.4 vs. 0.2 ± 0.1, F(1,34) = 7.81, p = .008, η p = .19) and stiffness than HCs (0.5 ± 0.4 vs. −0.6 ± 0.3, F(1,34) = 4.94, p = .033, η p = .213, Fig. 3B ).
Meditation effects
Exploratory mediation analyses were performed to examine whether the neuroendocrine (ACTH or cortisol) or inflammatory cytokine (IL-6, IL-8, IL-10 or TNF-α) response to exercise mediated changes in post-exertional symptoms. We found no significant mediation effects between group (FM or HC), exercise-induced changes in serum neuroendocrine and inflammatory analytes (mediators), and exerciseinduced changes in symptoms (muscle pain, fatigue, or stiffness). Implications of these findings are discussed below.
Discussion
Prior exercise interventions in FM have documented a worsening of symptoms in FM following high-intensity exercise. The purpose of the present study was to explore one potential mechanism underlying postexertional symptoms in FM. Specifically, we sought to generate preliminary evidence that insufficient muscle repair processes (blunted GH) and impaired anti-inflammatory mechanisms (blunted cortisol, IL-10 and IL-1RA) in FM patients result in an exaggerated pro-inflammatory cytokine response to unaccustomed exercise and consequently a worsening of muscle pain, stiffness and fatigue in the days post-exercise. Consistent with prior exercise interventions we found that in contrast to HCs, thigh muscle pain and tenderness increased in the FM group following exercise. FM participants also experienced increased fatigue and stiffness post-exertion. Thus, our findings are consistent with FM patients being more prone to post-exertional pain and tenderness than HCs. Although we hypothesized that insufficient muscle repair processes may contribute to the post-exertional symptom exacerbation observed in FM patients, our preliminary findings failed to support this idea. We found no difference in the exercise-induced GH response between FM and HC participants. Our data conflict with prior studies that showed a blunted GH response to exhaustive treadmill exercise in women with FM using the same modified Balke protocol (Jones et al., , 2007 Paiva et al., 2002) . This discrepancy may be related to the smaller sample size used in the present study or the close matching of FM and HCs on factors that influence the GH response to exercise. In addition to GH, serum levels of IL-6, IL-10, ACTH, and cortisol also increased during exercise in HCs, and in general peaked at VO 2 peak, before decreasing to pre-exercise levels an hour later. In contrast, serum levels of pro-inflammatory TNF-α and IL-8 decreased during exercise in HCs. These findings support the idea that exercise stimulates a neuroendocrine and anti-inflammatory cytokine response that decreases systemic inflammation in healthy individuals (Walsh et al., 2011) . We found that the exercise-induced anti-inflammatory cascade was blunted in women with FM. Specifically, the ACTH, cortisol, and IL-10 responses to exercise were blunted in FM patients relative to HCs. Aberrant ACTH and cortisol secretion in response to various stressors have previously been documented in people with FM (Adler et al., 1999; Paiva et al., 2002; Kadetoff and Kosek, 2010; Bote et al., 2012) . To our knowledge this is the first study to demonstrate a blunted exercise-induced IL-10 response in women with FM. The failure to mount the expected cortisol, and IL-10 response in FMs, both potent anti-inflammatory molecules may explain why TNF-α levels declined in HCs during exercise but not in FM participants. IL-6 infusion in healthy adults increases circulating levels of cortisol and IL-10 (Steensberg et al., 2003 ). Yet, the blunted IL-10 and cortisol response observed in FM participants in the present study did not appear to be related to a similarly blunted IL-6 response to exercise. IL-6 increased in both groups during exercise and then decreased toward baseline levels post-exercise. In the FM group, however, IL-6 levels did not fall as rapidly as in HCs in the hour post-exercise. A defect in IL-6 signaling rather than IL-6 secretion in FM may explain why in the context of a "normal" IL-6 response to exercise, downstream effectors of IL-6 were not optimally induced (Sarvas et al., 2013) .
Despite the blunted anti-inflammatory response observed in FM participants during and immediately after the exercise test, there were no group differences in IL-6, IL-10, and TNF-α at 2-and 4-days postexercise. In contrast, whereas IL-8 levels remained relatively constant in HCs in the days following exercise they decreased sharply in FM participants. The significance of the decline in serum IL-8 in FM relative to HCs is not clear. IL-8 is a chemokine that plays an important role in the infiltration of neutrophils to sites of inflammation and increased resting blood levels of IL-8 have been reported in FM and are associated with increased pain (Bazzichi et al., 2007; Ross et al., 2010; Ang et al., 2011; Bote et al., 2012 Bote et al., , 2013 . While engagement in low intensity exercise for several months has proven effective at reducing circulating IL-8 levels in FM and decreasing symptoms (Bote et al., 2013) , the acute IL-8 response to moderate to high intensity exercise has not been examined. We found no evidence that the increased post-exertional muscle pain and tenderness, stiffness, and fatigue were mediated by changes in circulating inflammatory cytokines either during exercise or in the following days. This finding does not necessarily rule out an inflammatory process in the exacerbation of these symptoms. The mediation analysis was likely underpowered in our study due to small sample size, decreasing our ability to detect these effects even if they were present. In addition, IL-1β and TNF-α act in a paracrine and autocrine manner and circulating levels of these cytokines may not necessarily reflect their activity in tissues i.e. damaged skeletal muscle. Indeed, the activation of immune cells following muscle damaging exercise, as evidenced by increased myoglobin levels, can occur without appreciable changes in circulating inflammatory markers (Kanda et al., 2013) . Measuring immune cell activation and their intracellular cytokine levels may be a more sensitive and practical approach to assessing exercise-induced immune changes in this population. This study has several limitations that should be addressed in future studies. First, FM participants were compared to HCs and not to women with other non-FM pain disorders. Thus, it is possible that group differences in the neuroendocrine and inflammatory responses to exercise observed in the present study are not specific to FM. Although Wingenfeld et al. showed neuroendocrine dysfunction in women with FM but not in women with chronic pelvic pain (Wingenfeld et al., 2008) , inclusion of a more appropriate control group is warranted in future exercise studies. Second, estradiol levels were not measured in the present study. Estradiol, the primary biologically active estrogen, has anti-inflammatory effects in humans (Puder et al., 2001 ). Although we found no group difference in estrogen status, based on self-reported last menstrual period and HRT usage, we acknowledge that a variation in estradiol levels could still occur and may have influenced the serum neuroendocrine and cytokine responses to exercise. The assessment of estradiol levels will be critical in follow-up studies. Finally, our sample size was relatively small and future studies are needed with a larger sample size to verify our findings.
